Gene therapy for restoring heart rhythm

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 5, 2014, Pages 426-438

  Boink, Gerard J J ^a,b   Robinson, Richard B ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cardiac arrhythmias; Cardiac electrophysiology; Gene therapy; Heart disease; Ion channels; Molecular biology; Pacemakers

Indexed keywords

ADENOVIRUS VECTOR; CYCLIC AMP; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; ORGANIC CATION TRANSPORTER 3; TRANSCRIPTION FACTOR SOX2; VIRUS VECTOR; CARDIOVASCULAR AGENT;

ADENO ASSOCIATED VIRUS; ANTIGEN PRESENTING CELL; ATRIOVENTRICULAR BLOCK; CALCIUM HOMEOSTASIS; CELL MEMBRANE CONDUCTANCE; CYTOTOXIC T LYMPHOCYTE; DIASTOLE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC VARIABILITY; HEART RATE; HEART RHYTHM; MEMBRANE POTENTIAL; NONHUMAN; NUCLEAR REPROGRAMMING; PACEMAKER; PARASYMPATHETIC TONE; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; SINUS BRADYCARDIA; SINUS NODE; UPREGULATION; ANIMAL; ARRHYTHMIAS, CARDIAC; DRUG EFFECTS; GENETICS; HEART; HEART FUNCTION TEST; HUMAN; PHYSIOLOGY; PROCEDURES;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR AGENTS; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; GENETIC THERAPY; HEART; HEART RATE; HUMANS; HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS; SINOATRIAL NODE;

EID: 84907912579     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248414528575     Document Type: Review

References (72)

1. Greenspon AJ, Patel JD, Lau E, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: Increasing complexity of patients and procedures. J Am Coll Cardiol. 2012;60(16):1540-1545.
2. Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91(4):500-506.
3. Peschar M, de SH, Michels KJ, Reneman RS, Prinzen FW. Left ventricular septal and apex pacing for optimal pump function in canine hearts. J Am Coll Cardiol. 2003;41(7):1218-1226.
4. van Geldorp IE, Vanagt WY, Prinzen FW, Delhaas T. Chronic ventricular pacing in children: Toward prevention of pacinginduced heart disease. Heart Fail Rev. 2011;16(3):305-314.
5. Potapova I, Plotnikov A, Lu Z, et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res. 2004;94(7):952-959.
6. Plotnikov AN, Shlapakova I, Szabolcs MJ, et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116(7):706-713.
7. Valiunas V, Kanaporis G, Valiuniene L, et al. Coupling an HCN2 expressing cell to a myocyte creates a pacing two cell syncytium. J Physiol. 2009;587(pt 21):5211-5226.
8. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22(10):1282-1289.
9. Mandel Y, Weissman A, Schick R, et al. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation. 2012; 125(7):883-893.
10. Rosen MR, Robinson RB, Brink PR, Cohen IS. The road biological pacing. Nat Rev Cardiol. 2011;8(11):656-666.
11. Boink GJ, Rosen MR. Regenerative therapies in electrophysiology and pacing: Introducing the next steps. J Interv Card Electrophysiol. 2011;31(1):3-16.
12. Kass-Eisler A, Falck-Pedersen E, Alvira M, et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A. 1993; 90(24):11498-11502.
13. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med. 1996;2(5):545-550.
14. Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: A comparative study with adenovirus vectors. Int J Cardiol. 2003;90(2-3):229-238.
15. Zsebo K, Yaroshinsky A, Rudy JJ, et al. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: Analysis of recurrent cardiovascular events and mortality. Circ Res. 2014;114(1):101-108.
16. Mingozzi F, Anguela XM, Pavani G, et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med. 2013;5(194):194ra92.
17. Jessup M, Greenberg B, Mancini D, et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation. 2011;124(3):304-313.
18. Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol Ther. 2001;4(4):383-391.
19. Bartel MA, Weinstein JR, Schaffer DV. Directed evolution of novel adeno-associated viruses for therapeutic gene delivery. Gene Ther. 2012;19(6):694-700.
20. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272(5259):263-267.
21. Cingolani E, Ramirez Correa GA, Kizana E, et al. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardi ac hypertrophy. Circ Res. 2007;101(2):166-175.
22. Niwano K, Arai M, Koitabashi N, et al. Lentiviral vectormediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther. 2008;16(6):1026-1032.
23. Annoni A, Goudy K, Akbarpour M, Naldini L, Roncarolo MG. Immune responses in liver-directed lentiviral gene therapy. Transl Res. 2013;161(4):230-240.
24. Naldini L. Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet. 2011;12(5):301-315.
25. Campochiaro PA. Gene transfer for ocular neovascularization and macular edema. Gene Ther. 2012;19(2):121-126.
26. Guy HM, McCloskey L, Lye GJ, Mitrophanous KA, Mukhopadhyay TK. Characterization of lentiviral vector production using microwell suspension cultures of HEK293T-derived producer cells. Hum Gene Ther Methods. 2013;24(2):125-139.
27. Stewart HJ, Leroux-Carlucci MA, Sion CJ, Mitrophanous KA, Radcliffe PA. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines. Gene Ther. 2009; 16(6):805-814.
28. Lakatta EG, DiFrancesco D.What keeps us ticking:Afunny current, a calcium clock, or both? J Mol Cell Cardiol. 2009;47(2):157-170.
29. Cohen IS, Robinson RB. Pacemaker current and automatic rhythms: Toward a molecular understanding. In: Clancy CE, Kass RS, eds. Basis and Treatment of Cardiac Arrhythmias. Berlin, Germany: Springer-Verlag; 2006:41-72.
30. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: from molecules to physiological function. Ann Rev Physiol. 2003;65:453-480.
31. Vinogradova TM, Lyashkov AE, Zhu W, et al. High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ Res. 2006;98(4):505-514.
32. DiFrancesco D, Ducouret P, Robinson RB. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science. 1989;243(4891):669-671.
33. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res. 2010;106(3):434-446.
34. Mattick P, Parrington J, Odia E, et al. Ca2+-stimulated adenylyl cyclase isoform AC1 is preferentially expressed in guinea-pig sino-atrial node cells and modulates the I(f) pacemaker current. J Physiol. 2007;582(pt 3):1195-1203.
35. Younes A, Lyashkov AE, Graham D, et al. Ca(2+) -stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J Biol Chem. 2008;283(21):14461-14468.
36. Maier SK, Westenbroek RE, Yamanushi TT, et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A. 2003;100(6):3507-3512.
37. Baruscotti M, Westenbroek R, Catterall WA, DiFrancesco D, Robinson RB. The newborn rabbit sino-atrial node expresses a neuronal type I - like Na+ channel. J Physiol. 1997;498(pt 3): 641-648.
38. Qu J, BarbutiA, Protas L, Santoro B, Cohen IS, Robinson RB. HCN2 over-expression in newborn and adult ventricular myocytes: distinct effects on gating and excitability. Circ Res. 2001;89(1):e8-e14.
39. Protas L, DunW, Jia Z, et al. Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc Res. 2009;81(3):528-535.
40. Boink GJ, Verkerk AO, van Amersfoorth SC, et al. Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer. J Gene Med. 2008;10(5):487-497.
41. den Haan AD, Veldkamp MW, Bakker D, et al. Organ explants culture of neonatal rat ventricles: A new model to study gene and cell therapy. PLoS One. 2013;8(3):e59290.
42. Robinson RB. Engineering a biological pacemaker: In vivo, in vitro and in silico models. Drug Discov Today Dis Models. 2009;6(3):93-98.
43. Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev. 2007;21(9):1098-1112.
44. Bakker ML, Boink GJ, Boukens BJ, et al. T-box transcription factor TBX3 reprogrammes mature cardiac myocytes into pacemaker-like cells. Cardiovasc Res. 2012;94(3):439-449.
45. Kapoor N, Liang W, Marban E, Cho HC. Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18. Nat Biotechnol. 2013;31(1):54-62.
46. Miake J, Marban E, Nuss HB. Gene therapy: Biological pacemaker created by gene transfer. Nature. 2002;419(6903):132-133.
47. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominantnegative suppression. J Clin Invest. 2003;111(10):1529-1536.
48. Robinson RB, Yu H, Chang F, Cohen IS. Developmental change in the voltage-dependence of the pacemaker current, if, in rat ventricle cells. Pflugers Arch. 1997;433(4):533-535.
49. Bucchi A, Plotnikov AN, Shlapakova I, et al. Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker. Circulation. 2006;114(10):992-999.
50. Zhao X, Bucchi A, Oren RV, et al. In vitro characterization of HCN channel kinetics and frequency-dependence in myocytes predicts biological pacemaker functionality. J Physiol. 2009; 587(pt 7):1513-1525.
51. Xue T, Siu CW, Lieu DK, Lau CP, Tse HF, Li RA. Mechanistic role of I(f) revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN) channels. Circulation. 2007;115(14):1839-1850.
52. Er F, Larbig R, Ludwig A, et al. Dominant-negative suppression of HCN channels markedly reduces the native pacemaker current I(f) and undermines spontaneous beating of neonatal cardiomyocytes. Circulation. 2003;107(3):485-489.
53. Plotnikov AN, Bucchi A, Shlapakova I, et al. HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with If blockade. Heart Rhythm. 2008;5(2):282-288.
54. Edelberg JM, Aird WC, Rosenberg RD. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J Clin Invest. 1998;101(2):337-343.
55. Edelberg JM, Huang DT, Josephson ME, Rosenberg RD. Molecular enhancement of porcine cardiac chronotropy. Heart. 2001; 86(5):559-562.
56. Ruhparwar A, Kallenbach K, Klein G, et al. Adenylate-Cyclase VI transforms ventricular cardiomyocytes into biological pacemaker cells. Tissue Eng Part A. 2010;16(6):1867-1872.
57. Kryukova Y, Protas L, Robinson RB. Ca2+-activated adenylyl cyclase I introduces Ca2+-dependence to b-adrenergic stimulation of HCN2 current. J Mol Cell Cardiol. 2012;52(6):1233-1239.
58. Bucchi A, Baruscotti M, Robinson RB, DiFrancesco D. If-dependent modulation of pacemaker rate mediated by cAMP in the presence of ryanodine in rabbit sino-atrial node cells. J Mol Cell Cardiol. 2003;35(8):905-913.
59. Qu J, Plotnikov AN, Danilo PJ, et al. Expression and function of a biological pacemaker in canine heart. Circulation. 2003;107(8): 1106-1109.
60. Plotnikov AN, Sosunov EA, Qu J, et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation. 2004;109(4):506-512.
61. Boink GJ, Duan L, Nearing BD, et al. HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates. J Am Coll Cardiol. 2013;61(11):1192-1201.
62. Boink GJ, Nearing BD, Shlapakova IN, et al. Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2. Circulation. 2012;126(5):528-536.
63. Tse HF, Xue T, Lau CP, et al. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation. 2006;114(10):1000-1011.
64. Cingolani E, Yee K, Shehata M, et al. Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block. Heart Rhythm. 2012;9(8):1310-1318.
65. Verkerk AO, van Ginneken AC, Wilders R. Pacemaker activity of the human sinoatrial node: role of the hyperpolarization-activated current, I(f). Int J Cardiol. 2009;132(3):318-336.
66. Cai J, Yi FF, Li YH, et al. Adenoviral gene transfer of HCN4 creates a genetic pacemaker in pigs with complete atrioventricular block. Life Sci. 2007;80(19):1746-1753.
67. Lu J, Wang HZ, Jia Z, et al. Improving cardiac conduction with a skeletal muscle sodium channel by gene and cell therapy. J Cardiovasc Pharmacol. 2012;60(1):88-99.
68. Boyden PA, Hirose M, Dun W. Cardiac Purkinje cells. Heart Rhythm. 2010;7(1):127-135.
69. Boink GJ, Lu J, Driessen HE, et al. Effect of skeletal muscle Na(+) channel delivered via a cell platform on cardiac conduction and arrhythmia induction. Circ Arrhythm Electrophysiol. 2012; 5(4):831-840.
70. Yokokawa M, Ohnishi S, Ishibashi-Ueda H, et al. Transplantation of mesenchymal stem cells improves atrioventricular conduction in a rat model of complete atrioventricular block. Cell Transplant. 2008;17(10-11):1145-1155.
71. Beeres SL, Atsma DE, van der Laarse A, et al. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J Am Coll Cardiol. 2005; 46(10):1943-1952.
72. Pijnappels DA, van TJ, de Vries AA, et al. Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts. Circulation. 2007;116(18): 2018-2028.